Transdermal nicotine patch enhances type I collagen synthesis in abstinent smokers. 2006

Lars T Sørensen, and Lars N Jorgensen, and Rikke Zillmer, and Jakob Vange, and Ulla Hemmingsen, and Finn Gottrup
Copenhagen Wound Healing Center, and Department of Surgery, Bispebjerg Hospital, University of Copenhagen, Denmark. lts@dadlnet.dk

Cigarette smokers deposit less collagen, expressed as hydroxyproline, in granulation tissue than nonsmokers. We studied the effect of abstinence from smoking and transdermal nicotine patches on deposition of hydroxyproline, proline, type I procollagen, and total proteins. Fifty-four healthy smokers were studied during 10 days of smoking and again from days 10 to 20 following smoking cessation. After the first 10 days of abstinence they were randomized to double-blind treatment with transdermal nicotine patches of 25 mg/day or placebo for a period of 10 days. During this period and during smoking, an expanded polytetrafluoroethylene tube was implanted into the subcutis. Following removal of the implant, total amino acids and peptides were extracted. Hydroxyproline and proline were analyzed by high-pressure liquid chromatography, type I procollagen was analyzed by enzyme-linked immunoassay, and total proteins were determined colorimetrically. In the 39 subjects who complied with the study protocol, abstinence from smoking did not affect the deposition of hydroxyproline, proline, type I procollagen, or total protein in the implants. During abstinence, the type I procollagen level increased by 18% in the transdermal nicotine patches group and decreased by 10% in the placebo group (p<0.05). We conclude that 20 days of abstinence from smoking does not affect collagen deposition in granulation tissue. However, in abstinent smokers, transdermal nicotine patches appears to increase type I collagen synthesis.

UI MeSH Term Description Entries
D008297 Male Males
D009538 Nicotine Nicotine is highly toxic alkaloid. It is the prototypical agonist at nicotinic cholinergic receptors where it dramatically stimulates neurons and ultimately blocks synaptic transmission. Nicotine is also important medically because of its presence in tobacco smoke. Nicotine Bitartrate,Nicotine Tartrate
D011392 Proline A non-essential amino acid that is synthesized from GLUTAMIC ACID. It is an essential component of COLLAGEN and is important for proper functioning of joints and tendons. L-Proline,L Proline
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006909 Hydroxyproline A hydroxylated form of the imino acid proline. A deficiency in ASCORBIC ACID can result in impaired hydroxyproline formation. Oxyproline,4-Hydroxyproline,cis-4-Hydroxyproline,4 Hydroxyproline,cis 4 Hydroxyproline
D000279 Administration, Cutaneous The application of suitable drug dosage forms to the skin for either local or systemic effects. Cutaneous Drug Administration,Dermal Drug Administration,Drug Administration, Dermal,Percutaneous Administration,Skin Drug Administration,Transcutaneous Administration,Transdermal Administration,Administration, Dermal,Administration, Transcutaneous,Administration, Transdermal,Cutaneous Administration,Cutaneous Administration, Drug,Dermal Administration,Drug Administration, Cutaneous,Skin Administration, Drug,Administration, Cutaneous Drug,Administration, Dermal Drug,Administration, Percutaneous,Administrations, Cutaneous,Administrations, Cutaneous Drug,Administrations, Dermal,Administrations, Dermal Drug,Administrations, Percutaneous,Administrations, Transcutaneous,Administrations, Transdermal,Cutaneous Administrations,Cutaneous Administrations, Drug,Cutaneous Drug Administrations,Dermal Administrations,Dermal Drug Administrations,Drug Administrations, Cutaneous,Drug Administrations, Dermal,Drug Skin Administrations,Percutaneous Administrations,Skin Administrations, Drug,Skin Drug Administrations,Transcutaneous Administrations,Transdermal Administrations

Related Publications

Lars T Sørensen, and Lars N Jorgensen, and Rikke Zillmer, and Jakob Vange, and Ulla Hemmingsen, and Finn Gottrup
February 1991, Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis,
Lars T Sørensen, and Lars N Jorgensen, and Rikke Zillmer, and Jakob Vange, and Ulla Hemmingsen, and Finn Gottrup
February 2011, Experimental and clinical psychopharmacology,
Lars T Sørensen, and Lars N Jorgensen, and Rikke Zillmer, and Jakob Vange, and Ulla Hemmingsen, and Finn Gottrup
August 2021, Microcirculation (New York, N.Y. : 1994),
Lars T Sørensen, and Lars N Jorgensen, and Rikke Zillmer, and Jakob Vange, and Ulla Hemmingsen, and Finn Gottrup
January 2008, Human psychopharmacology,
Lars T Sørensen, and Lars N Jorgensen, and Rikke Zillmer, and Jakob Vange, and Ulla Hemmingsen, and Finn Gottrup
May 2019, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco,
Lars T Sørensen, and Lars N Jorgensen, and Rikke Zillmer, and Jakob Vange, and Ulla Hemmingsen, and Finn Gottrup
December 2003, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco,
Lars T Sørensen, and Lars N Jorgensen, and Rikke Zillmer, and Jakob Vange, and Ulla Hemmingsen, and Finn Gottrup
April 2005, The American journal of cardiology,
Lars T Sørensen, and Lars N Jorgensen, and Rikke Zillmer, and Jakob Vange, and Ulla Hemmingsen, and Finn Gottrup
August 2023, Addiction (Abingdon, England),
Lars T Sørensen, and Lars N Jorgensen, and Rikke Zillmer, and Jakob Vange, and Ulla Hemmingsen, and Finn Gottrup
October 1996, Pediatrics,
Lars T Sørensen, and Lars N Jorgensen, and Rikke Zillmer, and Jakob Vange, and Ulla Hemmingsen, and Finn Gottrup
April 1993, Anesthesia and analgesia,
Copied contents to your clipboard!